Dr. Luis Ostrosky, professor of infectious disease at McGovern Medical School at UTHealth, co-investigator of first Texas randomized trial in hospitalized patients for convalescent therapy for COVID-19, is available to discuss latest data and FDA's hold on the emergency authorization of blood plasma treatment.

MEDIA CONTACT
Register for reporter access to contact details
RELEVANT EXPERTS